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ABSTRACT
Chlamydia trachomatis is the most prevalent agent of bacterial sexually
transmitted infections in the world. However, a profuse number of cases are
unreported, as the infection is often asymptomatic. Sequelae such as pelvic
inflammatory disease, an increased risk of cervical cancer, premature birth, and
perinatal infections in pregnant women can occur. Inflammation occurs in the
body in response to infection or injury. Although inflammation can lead to some
unwanted secondary effects, such as pain, it serves to return the body to
homeostasis by restoring injured tissues and eliminating pathogens. One recently
identified connection between the central nervous system and the immune
system that regulates inflammation is the cholinergic anti-inflammatory pathway
(CAP). In the CAP, pathogen-associated molecular patterns stimulate the vagus
nerve to activate the pathway, which ultimately results in acetylcholine (ACh)
release, which down regulates inflammation. We hypothesized that genital
chlamydial infection would increase the expression of choline acetyltransferase
(ChAT), the enzyme that synthesizes ACh, in the female murine genital tract,
therefore down regulating inflammation and promoting chlamydial infection.
Transgenic female mice carrying a ChAT-promoter driven GFP reporter gene
were vaginally infected with C. muridarum. Mice were sacrificed on days 3, 9, 15,
and 21 post infection; cervical, uterine horn, and ovarian tissues were removed
and embedded in paraffin. Small sections of each tissue were cut and mounted
onto slides. The tissue sections were then stained for the expression of ChAT
using immunohistochemical techniques. Finally, tissue sections were viewed
under a microscope for positive staining and the data was analyzed. The results
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indicated that there is a significant increase in the number of cells that express
ChAT in genital tract of chlamydia-infected mice versus non-infected mice.
INTRODUCTION
Chlamydia trachomatis is the most prevalent agent of bacterial sexually
transmitted infections in the world. One hundred one million infections are
caused by this bacterium each year, as reported by the World Health
Organization (Malhotra et al., 2013). However, a substantial number of cases are
unreported, as the infection is asymptomatic in 10% of men and 5-30% of
women. A sexually transmitted infection of Chlamydia trachomatis can manifest
as cervicitis, urethritis, and, or, proctitis (CDC, 2016). Sexually transmitted
infections caused by this agent are more common in women; sequelae such as
pelvic inflammatory disease, an increased risk of cervical cancer, premature
birth, and perinatal infections in pregnant women can occur. In fact, in the United
States about 20%-30% of cases of pelvic inflammatory disease are accounted for
by Chlamydia trachomatis. Reinfections or chronic infections with C. trachomatis
can occur, in which delayed hypersensitivity reactions can develop. The immune
response that ensues in these chronic infections can cause damage such as the
formation of scar tissue and fibrosis in the genital tract – which can lead to
infertility or life-threatening ectopic pregnancy (Malhotra et al., 2013). C.
trachomatis can also be transmitted from mother to child in the birth canal, which
can result in pneumonia and, or conjunctivitis in the neonate (Hogan et al., 2004).
C. trachomatis is a obligate intracellular Gram-negative pathogen with a
biphasic developmental cycle (Figure 1). First, elementary bodies enter host
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genital epithelial cells. Elementary bodies are infectious, but are less
metabolically active and unable to reproduce. Once inside the cell, within a
membrane bound vesicle called an inclusion, elementary bodies differentiate into
reticulate bodies. Reticulate bodies are more metabolically active than EB and
divide inside of the inclusion, but are unable to infect other cells. An unknown cue
causes the reticulate bodies to differentiate back into elementary bodies. These
progeny elementary bodies are released from the cell by either host cell rupture
or inclusion extrusion and can go on to infect other cells and repeat this
developmental cycle (Wolf et al., 2006).

EB
attachment
and entry

EB release
(lysis or
extrusion)

EB to RB
conversion

RB to EB
conversion
EB:
RB:
AB:

RB multiplication
and inclusion
enlargement

Figure 1. Chlamydial Developmental Cycle

5

Cholinergic neurotransmission is one of the central means by which the
body maintains homeostasis, and therefore life (Wessler and Kirkpatrick, 2008).
In animals, acetylcholine (ACh) is synthesized by the enzyme choline
acetyltransferase (ChAT) (Wessler et al., 1998). Cholinergic neurons release
ACh into the synaptic cleft; these neurotransmitters act on nicotinic and
muscarinic receptors to carry out neurotransmission. Not only is ACh an
important neurotransmitter, but it also has other important signaling functions.
Even in organisms like bacteria, fungi, algae, and protozoa, that do not have
neurons, cholinergic communication has been found (Wessler and Kirkpatrick,
2008). Thus, it is not surprising that the ChAT enzyme, ACh, and nicotinic and
muscarinic receptors for ACh have also been found in non-neuronal cells in
mammals. Many non-neuronal cells produce ACh, and most of these cell types
also express nicotinic and muscarinic receptors that play a role in the autocrine
and paracrine cholinergic regulation of non-neuronal cells (Wessler and
Kirkpatrick, 2008). These autocrine and paracrine loops regulate cellular
functions such as proliferation, differentiation, and migration (Wessler and
Kirkpatrick, 2008). It has been determined that ACh can also alter immune
responses. For example, release of proinflammatory molecules TNF and IL1-β
from macrophages that express α7 nicotinic receptors can be inhibited when
these cells are stimulated by ACh. This neuroinflammatory reflex is known as the
cholinergic anti-inflammatory pathway (CAP) (Wessler and Kirkpatrick, 2008).
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Inflammation occurs in the body in response to infection or injury.
Although inflammation can lead to some unwanted secondary effects, such as
pain, it serves to return the body to homeostasis by promoting healing within
injured tissues and eliminating pathogens (Pavlov et al., 2003). The CAP is a
recently identified connection between the central nervous system and the
immune system that suppresses inflammation. In this response, pro-inflammatory
cytokines, substances from necrotic tissues, and pathogen-associated molecular
patterns, which are substances unique to microbes, activate afferent fibers of the
vagus nerve (Reardon, 2016). This vagal sensory information is directed to the
nucleus tractus solitaries in the brainstem. Some neurons in the nucleus tractus
solitarius synapse with neurons in the rostral ventrolateral medulla. Neurons in
the roastrol ventrolateral medulla project to the locus coeruleus, which then
projects to sympathetic preganglionic neurons in the spinal cord (Pavlov et al.,
2003). Efferent vagal nerve fibers are also stimulated, which stimulate
postganglionic sympathetic fibers in the celiac ganglion. These activated neurons
release norepinephrine (NE) into the spleen, and likely into other organs as well.
A particular group of CD4+ T-cells have β-adrenergic receptors that bind NE,
which, upon NE binding, express the ChAT enzyme and release ACh (Reardon,
2016). Immune cells that produce cytokines express nicotinic acetylcholine
receptors (nAChR); ACh binds to the α7 subunit of these nAChR. As a result of
this binding, decreased NF-κB activation, pro-inflammatory cytokine and innate
immunity activity occurs (Tracey, 2009).
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The α7nAChR has been found to be expressed on macrophages, which
are the primary immune cells that initiate inflammatory responses. TNF produced
by LPS-activated macrophages can be dose-dependently decreased by ACh
(Pavlov et al., 2003). Gene knockout mice for the α7nAChR gene have been
found to be more sensitive to stimuli that induce inflammation. During
endotoxemia a considerable increase in IL-1, IL-6, and TNF was found in the
serum of the mice deficient in the α7nAChR versus the wild type mice. Although
vagus nerve stimulation reduces pro-inflammatory cytokines in wild type mice
with endotoxemia, mice deficient in the α7nAChR are unable to produce this
same response. Experiments have also been performed on rats to demonstrate
the role of the CAP in localized peripheral inflammation. In a rat with paw edema,
electrical stimulation of the distal vagus nerve reduced local inflammation.
Additionally, when the paw was treated with ACh, muscarine, or nicotine (all of
which are agonists that bind to and activate ACh receptors) prior to electrical
stimulation the local inflammation of the paw was inhibited. These experiments
demonstrate that vagal nerve stimulation or stimulation of α7nAChR
downregulates inflammation, which provides supporting evidence of CAP
function (Pavlov et al., 2003).
Research also indicates that stimulation of nAChR promotes pathogenesis
in some infections. In a mouse model of Staphylococcus pneumoniae infection,
inflammation and bacterial load in the lungs was significantly increased in mice
treated with nicotine (Giebelen et al., 2009). In another study, the bacterial load
and mortality in mice infected with Francisella tularensis was increased in groups
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treated with either ACh or an acetylcholinesterase inhibitor, neostigmine
(Pohanka et al., 2012). This data suggests that ACh can enhance pathogenesis
during infection, perhaps by reducing the host inflammatory response to infection
and, thereby, allowing the pathogen to evade host immune responses.
Therefore, we hypothesized that genital tract infection with C. muridarum would
increase the number of ChAT-expressing cells in the genital tract. If this
hypothesis is correct, we would also predict that this chlamydia-induced
production of ACh would reduce local inflammation and help the bacteria evade
the host immune response.
MATERIALS AND METHODS
Animal Infections
All protocols were approved by the University Committees on Animal
Care, Biosafety, and Hazardous Materials and followed by the applicable state
and federal guidelines. ChAT (BAC) eGFP female mice from Jackson Laboratory
(strain B.6Cg-Tg (RP23-268L19-EGFP) 2Mik/J; #007902) were injected
subcutaneously with 2.5mg/100µL medroxyprogesterone acetate suspension
from Greenstone Pharmaceuticals 7 days before vaginal infection with C.
muridarum. Vaginal swabs were taken for titers. The mice were then sacrificed
by cervical dislocation on the appropriate day post infection. Immediately upon
being sacrificed, the appropriate tissue was removed and fixed in formalin (10%
formaldehye). Two to 3 days later the tissue was moved to 70% ethanol (EtOH).
Tissue was then embedded in paraffin.
Cutting and mounting embedded samples
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Tissue samples embedded in paraffin were kept in the freezer or on ice
until immediately before they were cut. Imbedded tissues in blocks were cut into
5 µm sections using a microtome. Several sections were cut at once to form a
ribbon of tissue sections, which was transferred to a piece of cardboard. A razor
blade was then used to cut the strip into smaller, three to four section, strips.
These smaller strips were then transferred to a 43°C water bath. Sections were
then mounted onto glass microscope slides by lifting tissue sections out of the
water bath with a microscope slide. These slides were then set upright in a tray
to dry at room temperature for at least one day.
De-paraffinization and Tissue Rehydration
Slide-mounted sections were placed in an oven at 60°C for 1-3 hours to
melt the paraffin. After removing the slides and letting them cool to room
temperature, they were placed in glass boats and rehydrated in a series of baths.
Slides were first incubated in xylene baths twice for five minutes each. Slides
were then placed in 100% EtOH baths twice for two minutes each, then 95%
EtOH baths twice for two minutes each. Then slides were placed in 75% EtOH
baths for 2 minutes followed by a 50% EtOH bath for an additional 2 minutes.
Slides were then placed in a distilled water bath twice for 5 minutes each. Finally
slides were placed in 0.1M phosphate buffered saline (PBS) for 5 minutes.
Antigen retrieval proceeded immediately.
Antigen Retrieval
Rehydrated slides were spaced evenly in a tissue tech slide holder and
placed in its container. The container was then filled with Antigen Retrieval
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Solution (300mL dH2O + 0.882g sodium citrate, pH: 7). This was placed inside of
a microwave for 3.5 minutes at full power and then for 6 minutes set at defrost.
The container was removed from the microwave and allowed to cool to room
temperature. The slides were then washed in distilled water 3 times for 5 minutes
each. The Immunostaining Day 1 protocol started immediately or the slides were
placed in IHC PBS overnight.
Immunostaining Day 1
If completed the same day as the antigen retrieval protocol was
completed, slides were rinsed in IHC PBS (29.6g Na2HPO4 + 8.6g KH2PO4 +
14.4g NaCl + dH2O to make total volume 2L, pH 7.3) 4 times for 5 minutes each.
If the slides were left overnight in IHC PBS, slides were rinsed only 2 times for 5
minutes each. Slides were then rinsed with 0.5% bovine serum albumin (BSA)
solution made in IHC PBS. Slides were then rinsed with a 1% hydrogen peroxide
solution made in IHC PBS for 15 minutes. Then slides were rinsed with IHC PBS
4 times for 5 minutes each, followed by a 10 minute rinse in 0.5% BSA solution.
The slides were then removed from the tissue tech holder and then dried using a
kimwipe. A PAP pen was then used to draw a water barrier block around each
tissue section. The barrier was left to dry for up to a minute. Slides were then
placed into a humidity box and tissue sections were covered with a blocking
buffer made with 150 µl of goat serum (Vector Laboratories Catalog S-1000) and
10 mL of 1% BSA solution. The slides were left covered in the blocking buffer in
the humidity box for 2 hours at room temperature. The blocking buffer was then
poured off of the slides and replaced with the primary antibody solution of 1:1000
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dilution made of 3 µl of antibody (Anti-GFP antibody-ChIP Grade, Abcam ab290)
and 3 ml of blocking buffer or 25 µl of Rabbit IgG (Santa Cruz sc-2027) and 2 ml
of blocking buffer for control slides. The slides with the primary antibody covering
the tissue sections were incubated overnight in a humidity box at room
temperature.
Immunostaining Day 2
As each slide was removed from the humidity box it was rinsed with IHC
PBS. Then the slides were placed in the tissue tech holder and rinsed with IHC
PBS 4 times for 5 minutes each. Slides were then rinsed with 0.5% BSA solution
for 10 minutes. The slides were placed back in the humidity box and covered with
biotinylated secondary antibody solution. The biotinylated secondary antibody
solution was made using 10 mL of the blocking buffer used during
Immunostaining Day 1 and 1 drop of biotinylated secondary antibody from the
vectastain elite ABC kit (Vector Laboratory #PK-6101). The slides were left for 2
hours at room temperature in the humidity box. The secondary antibody solution
was then poured off and slides were rinsed with IHC PBS as they were removed
from the humidity box after the incubation. The slides were rinsed in IHC PBS 4
times for 4 minutes each, then rinsed with 0.5% BSA for 10 minutes. The slides
were then placed back in the humidity box and the tissue was covered with the
ABC reagent. The ABC reagent was made at least 30 minutes before use and
was made using 1 drop of solution A and 1 drop of solution B from the vectastain
elite ABC kit and 2.5 mL of 1.0% BSA solution. The slides were left in the
humidity box for 1.5 hours. The ABC reagent was then poured off of the tissue;
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each slide was rinsed with tris buffered saline (TBS) (6.35g Tris-HCl + 1.18g Tris
Base + 8.77g NaCl + 1L dH2O, pH 7.5) solution as it was removed from the
humidity box. The slides were rinsed with TBS 4 times for 5 minutes each. During
the last rinse the VIP substrate was prepared; it was made using 1.67 mL of IHC
PBS and 1 drop of solutions 1, 2, and 3 and hydrogen peroxide from Vector VIP
Peroxidase Kit (Vector Laboratories #SK-4100). The slides were placed onto a
white background. The tissue sections were covered with the VIP solution for 2
minutes to allow for color development.
After color development, each slide was rinsed with distilled water before
placing them back into the tissue tech holder. The slides were rinsed twice for 2
minutes each with distilled water to stop color development. The slides were then
again placed on the white background. The tissue sections were covered with
methyl green for 1 minute. The slides were then rinsed thoroughly with distilled
water. The slides were then placed into glass boats to undergo the dehydration
process, which is the reverse of the hydration process used during the Deparaffinization and tissue re-hydration step, starting with a 50% EtOH wash for 2
minutes and ending with two 5 minute xylene washes. The slides were then
wiped dry with a kimwipe, avoiding the tissue sections. Coverslips were then
attached using cytoseal. The slides were allowed to air dry in a hood overnight.
Quantification
After the slides were allowed to dry for at least one night, the tissue
sections were examined underneath a microscope at 630x magnification using
an oil immersion lens. Twelve fields were examined for each tissue section. The
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fields were taken starting at the top left corner of the tissue, moving right across
the tissue, then down at least one field, then moving back left across the tissue.
This zig-zag like technique was used across the entire tissue, randomly selecting
non-overlapping fields from all areas of the tissue section. A picture was taken of
each field under 630x oil immersion lens. The picture was then examined to
determine the number of positively stained cells. Dark cells with somewhat
defined edges that were also visible when directly looking through the
microscope were regarded as positively stained cells. The data was then
analyzed to determine the average number of positive cells per field in each
tissue section, microscope slide, mouse, infected mice samples, and mock mice
samples. Statistical significance was determined for the average number of
positively stained cells in mice infected with C. muridarum versus the noninfected mice using a two-tailed t test; p<0.05 was used for significance.
RESULTS
Previous preliminary work in the Schoborg lab determined that the number
of ChAT expressing cells increased in Chlamydia-infected cervical tissue
compared to mock-infected (uninfected) control on days 3-21 post infection
(Figures 2, 3). This preliminary data lead to further experiments, first confirming
significance in cervical tissue on day 9 post infection (Figure 4), then performing
staining experiments on both uterine horn and ovarian tissue on days 3-21 post
infection, labeled Chat 1 experiments (Figures 5, 6, 8, 9). Repeat experiments
were also performed on the day 9 post infection uterine horn, labeled Chat 2
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experiments (Figure 7) and ovarian tissue (Figure 10) to provide more data to
support or dispute the preliminary findings.

Figure 2. C. muridarum Infection Increases The Number of ChATexpressing Cells in Cervical Tissue Days 3-21 Post Infection. Cervical tissue
was immunostained for ChAT expression using the IHC technique. ChAT positive
cells were counted in random fields at magnification 630x under oil immersion.
The pictures are representative of stained sections that were counted for the
indicated day post infection. Arrows indicate the presence of positive staining for
the expression of ChAT. The day post infection that the mock tissue was
harvested is shown above each column of photographs. Mock indicates sections
from a mock-infected mouse; Cm infected indicates sections from a C.
muridarum infected mouse.
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Figure 3. C. muridarum Infection Increases the Number of ChAT-expressing
cells in Cervical Tissue Days 3-21 Post Infection. The cervical sections
stained for the experiment shown in Figure 2 were quantified and the average
number of cells expressing ChAT per 630x microscope field was calculated for
random fields, as described in the Methods section. The average number of
ChAT positive cells per field in cervical tissue is shown by the blue bars, in either
a mock-infected mouse (mock) and C. muridarum infected mouse (infected). The
time post infection that the tissue was harvested is shown above each graph.
Mock and infected ChAT positive cell counts were compared using a two-tailed t
test; p<0.05 was considered significantly different. P values obtained for each
comparison are shown in each graph. A statistically significant difference was
found in the number of cells expressing ChAT on days 3, 9, 15 and 21 post
infection with C. muridarum versus those that were not infected.
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Figure 4. C. muridarum Infection Increases Expression of ChAT in Cervical
Tissue on Day 9 Post Infection. The average number of cells expressing ChAT
per 630x microscope field was calculated using day 9 post infection cervical
tissue sections from 3 mice infected with C. murdarum as well as 3 non-infected
mice (mock) as a control. The asterisk signifies a statistically significant increase
determined using a two-tailed t test; p <0.05 was used for significance. The p
value for the indicated comparison is shown on the graph. These data were
obtained from the ChAT 2 experimental repeat.
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Figure 5. C. muridarum Infection Increases the Number of Chat-expressing
Cells in Uterine Horn Tissue Day 9 Post Infection. Uterine horn tissue was
immunostained for ChAT expression using the IHC technique. ChAT positive
cells were counted in random fields at magnification 630x under oil immersion.
The pictures are representative of stained sections that were counted for the
indicated day post infection. Arrows indicate the presence of positive staining for
the expression of ChAT. The day post infection that the tissue was harvested is
shown above each column of photographs. Mock indicates sections from a
mock-infected mouse; Cm infected indicates sections from a C. muridarum
infected mouse.
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Figure 6. C. muridarum Infection Increases the Number of ChAT-expressing
cells in Uterine Horn Tissue on Day 9 Post Infection. The uterine horn
sections stained for the experiment shown in Figure 5 were quantified and the
average number of expressing ChAT per 630x microscope field was calculated
as described in the Methods section. The average number of ChAT positive cells
per field in uterine horn tissue is shown by the blue bars, in either a mockinfected mouse (mock) and C. muridarum infected mouse (infected). The time
post infection that the tissue was harvested is shown above each graph. Mock
and infected ChAT positive cells counts were compared using a two-tailed t test;
p<0.05 was considered siginifcantly different. P values obtained for each
comparison are shown in each graph. A statistically significant difference was
found in the number of cells expressing ChAT on day 9 post infection with C.
muridarum versus those that were not infected.
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FIGURE 7. C. muridarum Infection Increases Expression of ChAT in
Uterine Horn Tissue Day 9 Post Infection. The average number of cells
expressing ChAT per 630x microscope field was calculated using day 9 post
infection uterine horn tissue sections from 3 mice infected with C. muridarum as
well as 3 non-infected mice (mock) as a control. The asterisk signifies a
statistically significant increase determined using a two-tailed t test; p<0.05 was
used for significance. The p value for the indicated comparison is shown on the
graph. These data were obtained from the ChAT 2 experimental repeat.
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Figure 8. C. muridarum Infection Increases the Number of ChAT-expressing
Cells in Ovarian Tissue Days 9-21 Post Infection. Ovarian tissue was
immunostained for ChAT expression using the IHC technique. ChAT positive
cells were counted in random fields at magnification 630x under oil immersion.
The pictures are representative of stained sections that were counted for the
indicated day post infection. Arrows indicate the presence of positive staining for
the expression of ChAT. The day post infection that the tissue was harvested is
shown above each column of photographs. Mock indicates sections from a
mock-infected mouse; Cm infected indicates sections from a C. muridarum
infected mouse.
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Figure 9. C. muridarum Infection Increases the Number of ChAT-expressing
cells in Ovarian Tissue Days 9-21 Post Infection. The ovarian sections stained
for the experiment shown in Figure 8 were quantified and the average number of
cells expressing ChAT per 630x microscope field was calculated for random
fields, as described in the Methods section. The average number of ChAT
positive cells per field in ovarian tissue is shown by the blue bars, in either a
mock-infected mouse (mock) and C. muridarum infected mouse (infected). The
time post infection that the tissue was harvested is shown above each graph.
Mock and infected ChAT positive cell counts were compared using a two-tailed t
test; p<0.05 was considered significantly different. P values obtained for each
comparison are shown in each graph. A statistically significant increase was
found in the number of cells expressing ChAT on days 9, 15, and 21 post
infection with C. muridarum versus that that were not infected.
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FIGURE 10. C. muridarum Infection Does Not Increase the Number of
ChAT-Expressing Cells in Ovarian Tissue on Day 9 Post Infection. The
average number of cells expressing ChAT per 630x microscope field was
calculated using day 9 post infection ovarian tissue sections from 3 mice infected
with C. muridarum as well as 3 non-infected mice (mock) as a control. It was
determined that there was not a significant increase in the number of ChATexpressing cells using a two t-tailed t test; p<0.05 was used for significance. The
p value for the indicate comparison is shown on the graph. These data were
obtained from the ChAT 2 experimental repeat.

Repeated staining experiments exhibited a significant increase in the
number of ChAT-expressing cells on day 9 post infection in the cervix (Figure 4),
supporting previous preliminary findings in the Schoborg lab. As expected, ChAT
expression was increased in Chlamydia-infected uterine horn on days 3, 9, and
21 post infection, with a statistically significant increase in the number of ChAT-
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expressing cells on day 9 (Figure 6). Repeated staining experiments on day 9
post infection uterine horn tissue supports the statistical significance found in the
preliminary experiments (Figure 7). Initial experiments on ovarian tissue found
an significant increase in ChAT-expressing cells on days 3, 9, 15, and 21 post
infection in infected tissue versus non-infected tissue (Figure 9). Repeated
experiments on day 9 post infection ovarian tissue did not find a significant
increase in the expression of ChAT between infected and non-infected tissue
(Figure 10).
DISCUSSION
Supporting our original hypothesis, data from repeated IHC staining
experiments on day 9 post infection cervical tissue exhibits a significant increase
in the number of cells expressing ChAT in C. muridarum infected tissue. Data
from uterine horn tissue exhibited a significant increase of ChAT expression on
day 9 post infection. Although initial experiments with ovarian tissue indicated a
significant increase of ChAT expression on day 9 post infection, repeated
experiments did not identify a significant difference. This may be the result of an
unevenly distributed infection of the ovarian tissue, which could have caused an
uneven distribution of ChAT-expressing cells in the ovarian tissue, as the tissue
sections used were very small portions of the entire ovary. More experiments
need to be carried out to determine if this disparity was due to experimental error,
or if there is truly no significant difference in ChAT expression in ovarian tissue
on day 9 post infection. Further experiments are also needed on all days post
infection to substantiate or refute the general initial findings of an increase in
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ChAT-expressing cells in Chlamydia-infected genital tract tissue versus noninfected tissue.

Figure 11. Possible Mechanisms of Enhancement of Chlamydial Infection

This increase in ChAT, and therefore Ach, in the genital tract could, in fact,
promote chlamydial infection through several different mechanisms (Figure 11).
Direct stimulation of nAChRs by nAChR agonists, including ACh, has been
shown to increase the growth of C. pneumoniae in human epithelial cells in vivo
(Yamaguchi et al., 2003). Stimulation of α7nAChR by its agonists has also shown
to decrease chemokines produced by macrophages resulting in decreased
migration of neutrophils to the area of infection (Su et al., 2010). ACh treatment
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also decreases expression of cellular adhesion molecules on endothelial cells,
preventing migration of neutrophils, and therefore destruction of microbes, in
infected tissues (Reardon et al., 2013). Human ovarian granulosa cells treated
with acetylcholine have increased estrogen secretion (Kornya, 2001). Increased
estrogen has been shown in animal models to increase both the severity and
longevity of genital chlamydial infection (Rank et al., 1982). Therefore, an
increase in production of acetylcholine in the genital tract could promote
chlamydial infection through any or several of these mechanisms.
As stated above, this data indicates that C. murdarium infection does
increase the expression of ChAT in the genital tract for at least days 3-21 post
infection. Although the mechanism is unknown, this could occur by activation of
CAP or a CAP-independent mechanism that causes the expression of ChAT in
genital cells. Therefore, the presence of ACh in the genital tract, or activation of
CAP, could promote genital chlamydial infections. These findings could be
applied to find new or improve current treatments for genital chlamydial infections
using pre-existing acetylcholinesterase inhibitors or AChR agonists or
antagnoists to treat these infections, and, or their sequelae.
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